These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 18565394

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
    Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo LC, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R.
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):62-6. PubMed ID: 16755592
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In-hospital and mid-term clinical outcomes after percutaneous coronary intervention with the use of sirolimus- or paclitaxel-eluting stents.
    Alidoosti M, Salarifar M, Kassaian SE, Zeinali AM, Nematipoor E, Sheikhfathollahi M, Poorhosseini H, Dehkordi MR, Abbasi A.
    Kardiol Pol; 2009 Dec; 67(12):1344-50. PubMed ID: 20054765
    [Abstract] [Full Text] [Related]

  • 26. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators.
    Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
    Li JJ, Xu B, Yang YJ, Chen JL, Qiao SB, Ma WH, Qin XW, Yao M, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Xia R, Gao RL.
    Chin Med J (Engl); 2007 Apr 05; 120(7):569-73. PubMed ID: 17442204
    [Abstract] [Full Text] [Related]

  • 29. Differential long-term outcomes of zotarolimus-eluting stents compared with sirolimus-eluting and paclitaxel-eluting stents in diabetic and nondiabetic patients: two-year subgroup analysis of the ZEST randomized trial.
    Jang SJ, Park DW, Kim WJ, Kim YH, Yun SC, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2013 Jun 01; 81(7):1106-14. PubMed ID: 22899589
    [Abstract] [Full Text] [Related]

  • 30. Crush stenting in treating coronary bifurcate lesions: paclitaxel eluting stents versus sirolimus eluting stents.
    Chen SL, Zhang JJ, Ye F, Chen YD, Zhu ZS, Lin S, Tian NL, Liu ZZ, Fang WY, Sun XW, Hu DY, Kwan TW.
    Chin Med J (Engl); 2008 Mar 20; 121(6):528-33. PubMed ID: 18364140
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry).
    Kaltoft A, Jensen LO, Maeng M, Tilsted HH, Thayssen P, Bøttcher M, Lassen JF, Krusell LR, Rasmussen K, Hansen KN, Pedersen L, Johnsen SP, Sørensen HT, Thuesen L.
    J Am Coll Cardiol; 2009 Feb 24; 53(8):658-64. PubMed ID: 19232897
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Sirolimus versus paclitaxel-eluting stents in small coronary vessels: long-term outcomes from a single-center registry.
    Bucalo R, Capranzano P, Conti G, Capodanno D, Ruperto C, Blundo A, Caggegi A, Tamburino C, Sanfilippo A, Tamburino C.
    J Cardiovasc Med (Hagerstown); 2010 May 24; 11(5):365-8. PubMed ID: 20150821
    [Abstract] [Full Text] [Related]

  • 39. Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study.
    Simsek C, Räber L, Magro M, Boersma E, Onuma Y, Stefanini GG, Zanchin T, Kalesan B, Wenaweser P, Jüni P, van Geuns RJ, van Domburg RT, Windecker S, Serruys PW.
    Int J Cardiol; 2013 Dec 05; 170(1):36-42. PubMed ID: 24196314
    [Abstract] [Full Text] [Related]

  • 40. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry.
    Williams DO, Abbott JD, Kip KE, DEScover Investigators.
    Circulation; 2006 Nov 14; 114(20):2154-62. PubMed ID: 17060386
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.